Real-world use of xanomeline/trospium chloride in a large academic healthcare system in the first year following FDA approval [0.03%]
Halide Bilge Türközer,Dost Öngür,Ann K Shinn
Halide Bilge Türközer
Social dysfunction and default mode network functional integrity in neuropsychiatric disorders: A cross-disorder replication and generalization study [0.03%]
Simon Braak,Maarten Mennes,Tanja Su et al.
Simon Braak et al.
Cross-disorder research and replication of neuroimaging findings remains scarce. Social dysfunction is an early manifestation across diverse neuropsychiatric disorders that may relate to altered default mode network (DMN) integrity. This st...
Lithium response in families can inform the selection of long-term treatment of bipolar disorder [0.03%]
M Alda,P Grof,J Garnham et al.
M Alda et al.
Lithium, recommended as the first-line choice for recurrence prevention in bipolar disorder, is fully effective in only about one-third of patients. It is therefore important to identify early those patients likely to benefit in the long-te...
A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice [0.03%]
S Y Smith-Apeldoorn,J K E Veraart,J Kamphuis et al.
S Y Smith-Apeldoorn et al.
Age-stratified associations between severe mental illness, dementia, and ischemic stroke: findings from the PADRIS-PRESTO cohort [0.03%]
来自PADRIS-PRESTO队列的严重精神疾病、痴呆与缺血性卒中年龄分层关联分析结果
Michele De Prisco,Vincenzo Oliva,Raquel Sanchez-Valle et al.
Michele De Prisco et al.
People with severe mental illnesses (SMIs), including schizophrenia spectrum disorders (SSD), major depressive disorder (MDD), and bipolar disorder (BD), experience elevated rates of physical comorbidity and premature mortality. Dementia an...
Perinatal bipolar disorder as a critical risk window: rationale for hospitalization at home on this population [0.03%]
围产期双相情感障碍作为关键风险窗口：该人群居家住院的合理性
Marina Garriga,Alba Roca-Lecumberri
Marina Garriga
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37] [0.03%]
关于“多基因风险评分通过认知和临床特征介导青年家族高危人群和对照组的功能结局”一文的勘误(欧洲神经精神药理学杂志第81卷(2024年)28-37页)
Alex G Segura,Elena de la Serna,Gisela Sugranyes et al.
Alex G Segura et al.
Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27] [0.03%]
关于《N,N-二甲基色胺蒸汽的安全性、耐受性和主观效果：一项随机双盲临床试验》的勘误(欧洲神经精神药理学杂志第97卷(2025年)16-27页)
Isabel Wießner,Marcelo Falchi-Carvalho,Sophie Laborde et al.
Isabel Wießner et al.
Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential [0.03%]
血清素受体中血清素致幻剂的选择性信号传导：对精神活性、安全性和治疗潜力的影响
Deborah Rudin,Jan Valenta,Helene Rolli et al.
Deborah Rudin et al.
Serotonergic psychedelics primarily exert their effects through activation of the serotonin (5-HT) 2A receptor (5-HT2AR). However, the full pharmacological profiles of these substances involve multiple serotonin receptor subtypes and intrac...
Response to "Gene-environment interactions and white matter integrity in mood disorders: Further directions" [0.03%]
心情障碍中基因-环境相互作用和白质完整性的研究进展及展望的评论回应
Marco Paolini,Laura Raffaelli,Francesco Benedetti et al.
Marco Paolini et al.